Fast effectiveness of a solubilized low-dose budesonide nasal spray in allergic rhinitis.

Petra ZieglmayerRené SchmutzPatrick LemellNicole Unger-ManhartSabine NakowitschAndreas GoesslMarkus SavliRené ZieglmayerEva Prieschl-Grassauer

Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2020)

The novel preservative-free, aqueous low-dose budesonide formulation is highly efficacious even after an initial single treatment. Thus, Budesolv 10 appears to be an effective acute treatment for allergic rhinitis as well as for AR comorbidities like mild asthma and conjunctivitis.

Keyphrases

allergic rhinitis
low dose
randomized controlled trial
high dose
systematic review
drug delivery
liver failure
ionic liquid
intensive care unit
drug induced
acute respiratory distress syndrome
aortic dissection